MPO and COVID-19: Despite similar levels of the myeloperoxidase (MPO)–DNA complex between mild versus control and moderate versus severe COVID-19 cases, histone–DNA was higher in the moderate and severe COVID-19 cases than the mild cases and the control (Figure 4F).